MVT-201 - Microviable Therapeutics S.L.

Microviable Therapeutics will be presenting at Microbiome Connect USA

adminMicroVi2023-11-14T11:28:46+01:0014 de November de 2023|

Microviable Therapeutics will participate in Microbiome Connect USA that will take place from November 14th to 16th in Boston. Claudio Hidalgo Cantabrana, CEO at Microviable, will join a like-minded community of 300 scientists and entrepreneurs [...]

Microviable Therapeutics seeks more than five million to secure a clinical trial

adminMicroVi2023-09-07T09:03:29+02:007 de September de 2023|

Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]